Epidemiological Survey of Toxoplasmosis among Aborted Women in Garmian district, Kurdistan Region, Iraq

Abstract = 548 times | PDF = 151 times

Main Article Content

Salar Ibrahim Ali


Toxoplasmosis is a zoonotic infection that caused by an obligated intracellular parasite Toxoplasma gondii of many types of tissues, including nervous, muscular and intestinal epithelial tissue. Congenital toxoplasmosis is most severe condition when occurs in early period of pregnancy. The main aim of this study is to determine prevalence of toxoplasmosis among aborted women in Garmian region by using both Latex Agglutination Test (LAT) and Enzyme Linked Immunosorbent Assay (ELISA). The study was carried out in Kalar General Hospital to detect Toxoplasma antibodies among 350 samples, in which 250 samples were from aborted women and 100 samples were from normal birth women as a control. Participants’ age was range from < 18 to > 35 years old. The data were collected form 15th January 2009 to 25th June 2010 by using a special questionnaire form to obtain full information from each participant. For statistical analysis of the data, Statistical Package for Social Sciences (SPSS) version 22 was used. The study showed that (112) cases out of 250 were seropositive for Toxoplasma gondii by using LAT, (65) cases for IgG and (50) cases for IgM by using ELISA. In the abortion group, it showed (87) cases out of 150 were seropositive by using LAT, (51) cases for IgG and (40) cases for IgM (26.6%), whereas in normal birth group (control), it showed (25) case out of 100 were seropositive by using LAT, (14) case for IgG and (10) case for IgM by using ELISA. A High seropositivity percentage was recorded among housewives (35.2%) than teachers and employees (29.4%), (28.5%) respectively. Furthermore, a higher percentage of Toxoplasma seropositivity was recorded in rural area than urban area. The aborted women who were in contact with soil showed the higher rate of Toxoplasma seropositivity (38.7%) than those were not in contact with soil (25%). This study concluded that the prevalence of toxoplasmosis was higher in Garmian region and especially among those women who have lower education level and who live in rural areas. 


Epidemiological Survey, Toxoplasmosis, Aborted women, Garmian, Immunological tests.


Download data is not yet available.

Article Details


[1] J.S Remington, R. McLeod, P. Thulliez, G, Desmonts, G, “Toxoplasmosis, Infectious diseases of the fetus and newborn infant,” In Remington, J.S. and Klein, J. 5th(Ed.). W. B. Saunders, Philadelphia: 205, 2001.
[2] J. G. Montoya, O. Liesenfeld, “Toxoplasmosis,” Lancet.; 363 (9425): (2004).
[3] E. A. Shevkunova, L. A. Pohina, M. F. Nugumanova, “A case of chronic acquired toxoplasmosis with positive agents detectable in the blood,”. Med. Parasitol. (Mosk), 44: 235-238. 1975.
[4] D. M. Israelski, J. S. Remington, “Toxoplasmosis in the non-AIDS immunocompromised host,” In Remington, J. S. and Swartz, M.N (ed.) Curr. Clin. Top. Infect. Dis., 13 Cambridge Mass. Black Well Scientific: 13: 322-356, 1993.
[5] R.G. Emerson, E. S. Milvenan, G. J. Elfenbein, R. Saral, “A plastic anemia developed seizure with bone marrow was successfully transplanted from a genotypical HL-A identical brother,” Pediatrics, 67: 653, 1981.
[6] S. S. Gange, “Toxoplasmosis,” Primary care update. Obstet. Gynecol., 8(31): 122-126, 2001.
[7] D. T. John, J. W. A. Petri, “Markell and Voge’s Medical parasitology,” 9th ed. W. B. Saunders Elsevier, Philadelphia, U.S.A.: 160- 175, 2006.
[8] S. Martin, “Congenital toxoplasmosis,” Neonatal Netw, 20 (4):23, 2001.
[9] J. L. Jones, D. L. Hanson, M. S. Dworkin, “Surveillance for AIDS-defining opportunistic illnesses, 1992–1997,”. Mor Mortal Wkly Rep CDC. Surveill. Summ., 48(2): 1–22., 1999.
[10] R. Lopez, R. Contreras, L. Font, O. Vega, “Presence of antibodies against Toxoplasma gondii in adolescents,” Rew. Latinoam. Microbiol., 34(1): 49-52. 1992.
[11] H. A. Feldman, “Epidemiology of Toxoplasma infection,” Epidemiol. Rev., 4: 204-213, 1982.
[12] B. H. Kean, “Clinical toxoplasmosis—50 years,” Trans. Royal. Soc. Trop. Med. Hyg., , 66(4): 549-571, 1972.
[13] A. J. Al-Khariri, “Seropidemiological serological study of toxoplasmosis in Diyala province /Iraq,” M.Sc. Thesis, College of Education, University of Diyala, 2007.
[14] R. L. Al- Timimi, “Detection of toxoplasmosis among different groups of aborted women during gestational age of pregnancy,” Diploma, Thesis, College of Medical and Health Technology, 2004.
[15] F. A.M. Fatohi, “Detection of toxoplasmosis among different groups of populations in Mousl city by using IFAT and CFT,” M.Sc. Thesis, College of Medicine, University of Mousl. 1985.
[16] S. A. Al-Attar, “Epidemiological study of toxoplasmosis in Kirkuk city,”. M.Sc. Thesis, College of Education. Tikrit University, 2000.
[17] A. N. Jasim, “Seroepidemiological Studies of Toxoplasmosis in Iraq: Evaluation of Serological Tests Used in Diagnosis,” M.Sc. Thesis, College of Medicine, University of Baghdad, 1979.
[18] A. R. Al-Jubori, “Parasitological and immunological study of Toxoplasma gondii in Kirkuk province,” M.Sc. Thesis, College of Medicine, Baghdad University, 2005.
[19] V. D. Saeed, “Seroprevalence of toxoplasmosis in women with repeated abortion and in children with congenital blindness and mental retardation in Erbil,” M.Sc. Thesis. College of Education, University of Salahaddeen, 1998.
[20] F. H. O. Al-Khaffaf, “Isolation and seroepidemiological study of toxoplasmosis among women in child bearing age in Nineveh governorate,” M.Sc. Thesis, College of Science, University of Mosul, 2001.
[21] B. D. Al-Doski, “Seroepidemiological study of toxoplasmosis among different groups of population in Duhok city by using latex agglutination test and indirect haemoagglutination test,” M.Sc. Thesis, College of Medicine, University of Duhok, 2000.
[22] B. Akoijaam, S. Shashikant, S. Kapoor, “Seroprevalence of Toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India,” J. Indian. Med. Asso., 100:591-601, 2002.
[23] D. Ashburn, “History and general epidemiology. Human toxoplasmosis,” Volume 3. Edited by: Ho Yen DO, Joss AWL. Oxford University Press Chapter: 56-76, 1992.
[24] E. Sema, O. Pinar, T. Munevver, Y. Hasan, “Seroprevalence and risk factors for toxoplasm infection among pregnant women in Aydin province,” Turkey. BMC Public Health. (5): 66. ,2005.
[25] A. E. Ades, S. Parker, R. Gilbert, P. A. Tookey, T. Berry, M. Hjelm, A. H. Wilcox, D. Cubitt, C. S. Peckham, “Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis’” Epidemiol. Infect., 110(1):127-133, 1993.
[26] S. Yazar, B. Altunoluk, A. Akman, I. Şahin, “Investigation of anti- Toxoplasma gondii antibodies in women during pregnancy,” Acta Parasitologica Turcica., 24(4):343-345, 2000.
[27] R. Attia, M. El- Zayat, H. Rizk, S. Motawea, “Toxoplasma IgG and IgM antibodies. A case control study,” J. Egypt. Soc. Parasitol., 25: 866-82, 1995.
[28] Y. R. Joshi, S. V. Yas, K. R. Josh, “Seroprevalence of Toxoplasmosis in Jodhpur, India,” J. Commun. Dis., 30 (1) :32-37, 1998.
[29] G. Kapperud, P. A. Jenum, B. Stray-Pedersen, K.K. Melby, A. Eskild, J. Eng, “Risk factors for Toxoplasma gondii infection in pregnancy: results of a prospective case-control study in Norway,” Obstet. Gynecol. Surv., 52: 158-9, 1997.
[30] D. H. M. Joynson, “Epidemiology of toxoplasmosis in the U.K,” Scand. J. Infect. Dis., 84 (suppl.): 65, 1992.
[31] L. Baril, “Facteurs de risqué d acquisition de la toxoplasmose chez les femmes enceintes en 1995 (France). Risk factors for acquiring toxoplasmosis in pregnant women in 1995 (France),” Bulletin epidemiologique hebdomadaire. 16: 73-75, 1996.